Genzyme Sues to Block Zimmer, Anika Treatments for Knee Pain

Genzyme Corp., the drugmaker bought by Sanofi-Aventis SA this month, sued Zimmer Holdings Inc. and Anika Therapeutics Inc. alleging the companies’ treatments for arthritic knee pain infringe a patent.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.